Try our Advanced Search for more refined results

Sandoz Gets Investor Suit Over Oriel Buyout Trimmed

By Y. Peter Kang (March 18, 2015, 4:25 PM EDT) -- A New York state judge has dismissed the bulk of claims in a shareholder suit against Sandoz Inc. for allegedly stalling development of a drug to avoid paying milestone bonuses to Oriel Therapeutics Inc. investors after its acquisition of Oriel but allowed the main claim to move forward....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!